To further evaluate the generalizability of our findings, future studies should include organoids derived from patients carrying other GBA variants or additional PD-linked mutations (e.g., LRRK2, SNCA, and Miro1) to assess reproducibility across diverse genetic backgrounds. This evidence concerns the gene RHOT1 and Parkinson disease.